SYSTEMIC SCLEROSIS

[1]  A. L. de Sá Pinto,et al.  Aerobic Exercise is Safe and Effective in Systemic Sclerosis , 2009, International journal of sports medicine.

[2]  M. Fogelholm.  Faculty Opinions recommendation of Cardiorespiratory fitness and adiposity as mortality predictors in older adults. , 2008 .

[3]  F. Roufosse,et al.  SYSTEMIC SCLEROSIS (SCLERODERMA) , 2007, Acta clinica Belgica.

[4]  C. Turesson,et al.  Cardiovascular risk factors, fitness and physical activity in rheumatic diseases , 2007, Current opinion in rheumatology.

[5]  David Abraham,et al.  Systemic sclerosis: a prototypic multisystem fibrotic disorder. , 2007, The Journal of clinical investigation.

[6]  R. Hornung,et al.  Health values of patients with systemic sclerosis. , 2007, Arthritis and rheumatism.

[7]  A. L. de Sá Pinto,et al.  Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement , 2007, Scandinavian journal of rheumatology.

[8]  B. Saltin,et al.  Evidence for prescribing exercise as therapy in chronic disease , 2006, Scandinavian journal of medicine & science in sports.

[9]  T. V. Vliet Vlieland,et al.  Safety of exercise in patients with rheumatoid arthritis , 2005, Current opinion in rheumatology.

[10]  K. Mannerkorpi,et al.  Exercise in fibromyalgia , 2005, Current opinion in rheumatology.

[11]  J. Weir.  Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. , 2005, Journal of strength and conditioning research.

[12]  S. Crouse,et al.  Effects of resistance, endurance, and concurrent exercise on training outcomes in men. , 2004, Medicine and science in sports and exercise.

[13]  C. Stenström,et al.  Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[14]  R. Zeballos,et al.  Clinical exercise testing. , 2001, Clinics in chest medicine.

[15]  A. Silman,et al.  European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes , 2001, Annals of the rheumatic diseases.

[16]  F. Balsano,et al.  Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis , 2000, Scandinavian journal of rheumatology.

[17]  L. Cosmi,et al.  Opposite role for interleukin‐4 and interferon‐γ on CD30 and lymphocyte activation gene‐3 (LAG‐3) expression by activated naive T cells , 1997, European journal of immunology.

[18]  G. Pizzolo,et al.  In vivo CD30 expression in human diseases with predominant activation of Th2‐like T cells , 1997, Journal of leukocyte biology.

[19]  R. Flavell,et al.  Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. , 1997, Journal of immunology.

[20]  R. V. van Lier,et al.  CD30 expression does not discriminate between human Th1- and Th2-type T cells. , 1996, Journal of immunology.

[21]  L. Notarangelo,et al.  CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2‐mediated condition , 1996, European journal of immunology.

[22]  A. Scheynius,et al.  Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation , 1995, Journal of leukocyte biology.

[23]  F. Finkelman.  Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease , 1995, The Journal of experimental medicine.

[24]  S. Jimenez,et al.  Elevated levels of eosinophil major basic protein in the sera of patients with systemic sclerosis. , 1995, Arthritis and rheumatism.

[25]  M. Croft,et al.  Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. , 1995, Journal of immunology.

[26]  P. Thompson,et al.  ACSM's Guidelines for Exercise Testing and Prescription , 1995 .

[27]  M. Fujimoto,et al.  Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma , 1995, Archives of Dermatological Research.

[28]  M. de Carli,et al.  Preferential expression of CD30 by human CD4+ T cells producing Th2‐type cytokines , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  M. Brunori,et al.  Presence and distribution of endothelin-1 gene expression in human kidney. , 1994, The American journal of physiology.

[30]  F. Annunziato,et al.  Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection , 1994, The Journal of experimental medicine.

[31]  M. de Carli,et al.  Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. , 1994, Science.

[32]  H. Stein,et al.  High serum level of the soluble form of CD30 molecule in the early phase of HIV‐1 infection as an independent predictor of progression to AIDS , 1994, AIDS.

[33]  W. Paul,et al.  CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3 , 1994, The Journal of experimental medicine.

[34]  N. Collop,et al.  Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. , 1993, The American journal of medicine.

[35]  N. Copeland,et al.  CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF , 1993, Cell.

[36]  L. Fabbri,et al.  Allergen exposure induces the activation of allergen‐specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders , 1993, European journal of immunology.

[37]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[38]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[39]  C. Heusser,et al.  Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation , 1993, The Journal of experimental medicine.

[40]  P. De Baetselier,et al.  Preferential activation of Th2 cells in chronic graft-versus-host reaction. , 1993, Journal of immunology.

[41]  P. Howarth,et al.  Interleukin 4 is localized to and released by human mast cells , 1992, The Journal of experimental medicine.

[42]  H. Katai,et al.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. , 1992, The Journal of clinical investigation.

[43]  A. Freemont,et al.  Sequential dermal microvascular and perivascular changes in the development of scleroderma , 1992, The Journal of pathology.

[44]  R. Carey,et al.  Spatial association of renin-containing cells and nerve fibers in developing rat kidney , 1991, Pediatric Nephrology.

[45]  J. Bos,et al.  High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. , 1991, The Journal of investigative dermatology.

[46]  K. Fredens,et al.  Eosinophil activation in systemic sclerosis. , 1991, Arthritis and rheumatism.

[47]  Diane Podsiadlo,et al.  The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.

[48]  A. Santoni,et al.  Soluble interleukin‐2 receptor, interleukin‐2 and interleukin‐4 in sera and supernatants from patients with progressive systemic sclerosis , 1990, Clinical and experimental immunology.

[49]  J. Korn.  Immunologic aspects of scleroderma , 1989, Current opinion in rheumatology.

[50]  R. González-Amaro,et al.  Mononuclear cell-fibroblast interactions in scleroderma. , 1988, Clinical immunology and immunopathology.

[51]  T. Whiteside,et al.  Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. , 1984, Arthritis and rheumatism.

[52]  G. Janossy,et al.  LYMPHOID INFILTRATES IN SKIN IN GRAFT-VERSUS-HOST DISEASE , 1981, The Lancet.

[53]  J. R. Reeves,et al.  Cellular infiltrates in scleroderma skin. , 1977, Arthritis and rheumatism.

[54]  G. Andrew,et al.  Influence of growth and athletic training on heart and lung functions , 1976, European Journal of Applied Physiology and Occupational Physiology.

[55]  G. Pizzolo,et al.  CD30, Th2 cytokines and HIV infection: a complex and fascinating link. , 1995, Immunology today.

[56]  R. Seder,et al.  T helper cell differentiation in immune response. , 1995, Current opinion in immunology.

[57]  S. Romagnani.  Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.

[58]  K. Newcomer,et al.  Validity and reliability of the timed-stands test for patients with rheumatoid arthritis and other chronic diseases. , 1993, The Journal of rheumatology.

[59]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[60]  H. Clarke.  Application of Measurement to Health and Physical Education , 1967 .